Table 4 Univariate and multivariate analyses of ANRIL expression between control and case group.
From: Expression ratio of circular to linear ANRIL in hypertensive patients with coronary artery disease
| Â | Control | Case | Unadjusted P | P* | P** | P*** |
|---|---|---|---|---|---|---|
Circular ANRIL | 1.00 ± 0.43 | 0.76 ± 0.37 | 0.042 | 0.081 | 0.043 | 0.157 |
Linear ANRIL | 1.00 ± 0.64 | 2.86 ± 1.65 |  < 0.0001 | 0.001 | 0.015 | 0.043 |
Circular/Linear ANRIL | 1.00 ± 0.51 | 0.39 ± 044 |  < 0.0001 | 0.003 | 0.010 | 0.053 |